Clarke Futch to Speak on BioWorld Webinar
ATLANTA, GA – April 29, 2013 – BioWorld® Today, biotech’s top news source, today announced it will be hosting a webinar titled “Royalty Financing for Biotech and Medical Device Companies: How to Determine Eligibility and Take Advantage of this Unique Financing Opportunity”.
“We have seen an increased level of activity in the royalty financing market over the past few years as companies continue to look for alternative sources of capital to fuel their pipelines,” said BioWorld® Today Executive Editor Lynn Yoffee. “Our team has brought together several experts who will provide an inside look into this growing market including intellectual property assets that appeal to royalty buyers, an overview of the deal structures and most importantly why companies are pursuing this innovative source of financing.”
Following are the webinar details:
|Date:||Thursday, May 2, 2013|
|Moderator:||Lynn Yoffee, Executive Editor, BioWorld® Today|
|Participants:||Clarke Futch, Founding Managing Director, HealthCare Royalty Partners
Wendy DiCicco, Chief Financial Officer, Nuron Biotech
Nicole Wicker, Chief Financial Officer, TearScience
About BioWorld® Today:
BioWorld® Today, and its analytical companion, BioWorld Insight, are the biopharmaceutical industry’s most respected news sources and have been for more than two decades. All of that information is now leveraged in BioWorld Data, business intelligence for biopharmaceutical executives. Biopharmaceutical Royalty Rates Analysis: Essential Benchmarks for Dealmaking is a new BioWorld Data tool that analyzes hundreds of licensing deals to provide a tangible starting point for deal negotiations. Call for details (800) 477-6307 or visit www.bioworld.com. Follow BioWorld® Today at www.twitter.com/BioWorld.
# # #